360. THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS
Bibliographic record
Abstract
Background: Anti-neutrophil cytoplasm antibodies (ANCA) may be pathogenic in ANCA- associated vasculitis. Rapid removal of ANCA by plasma exchange as an adjuvant to immune suppression and glucocorticoids may prevent progressive disease resulting in end-stage renal disease and death. Methods: We performed an open-label, 2-by-2 factorial randomized trial to separately evaluate plasma exchange and two regimens of oral glucocorticoids in patients with severe ANCA-associated vasculitis defined by glomerular filtration rate < 50ml/min or diffuse lung hemorrhage or both. To evaluate plasma exchange, participants were randomly assigned to either 7 plasma exchanges in 14 days or no plasma exchange. All patients received intravenous glucocorticoids and a tapering course of oral glucocorticoids, with cyclophosphamide or rituximab. Patients were followed up to 7 years for the primary composite outcome of death from any cause or end-stage renal disease. Results: The primary outcome occurred in 100 of 352 patients (28.4%) in the plasma exchange group and 109 of 352 patients (30.9%) in the control group (hazard ratio 0.86, 95% confidence interval [CI] 0.65 to 1.13; p = 0.27). No benefits were detected for either component of the primary outcome (hazard ratio for death 0.87, 95% CI 0.59 to 1.29 and for end-stage renal disease 0.81, 95% CI 0.57 to 1.13). There was no evidence of benefit in any pre-defined subgroup. Sixty-four percent of patients in both groups experienced at least one serious adverse event. Conclusion: Plasma exchange did not reduce the risk of death or end-stage renal disease in patients with severe ANCA-associated vasculitis. Disclosures: National Institute for Health Research (UK): HTA 08/56/04; Food and Drug Administration/National Institutes of Health (USA): FDA R01 FD003516 and the National Institutes of Health (USA) - National Institute of Arthritis and Musculoskeletal and Skin Diseases: U54 AR0573319; National Health and Medical Research Council (Australia): 626939; National Health and Medical Research Council (Australia): APP1086192; National Health and Medical Research Council (Australia): 631731; National Health and Medical Research Council (Australia): APP1092957; Canadian Institutes of Health Research (Canada): 211079; Canadian Institutes of Health Research (Canada): 159662, French Ministry of Health Programme Hospitalier de Recherche Clinique (France): AOM11142, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan; and The Japan Agency for Medical Research and Development (AMED): The Strategic Study Group to Establish the Evidence for Intractable Vasculitis Guideline (Japan); TermuoBCT, TerumoBCT Mexico, Fresenius Medical Care Australia, Baxter Healthcare Pty Ltd (Australia), and Asahi Kasei Medical Co., Ltd. provided in-kind plasma exchange disposables.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.002 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.004 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".